Kurt De Vlam
About
In The Last Decade
Kurt De Vlam
14 papers receiving 710 citations
Peers
Comparison fields: 5 of 46
- Rheumatology 651
- Immunology 267
- Hematology 169
- Orthopedics and Sports Medicine 134
- Surgery 111
Countries citing papers authored by Kurt De Vlam
This map shows the geographic impact of Kurt De Vlam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt De Vlam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt De Vlam more than expected).
Fields of papers citing papers by Kurt De Vlam
This network shows the impact of papers produced by Kurt De Vlam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt De Vlam. The network helps show where Kurt De Vlam may publish in the future.
Co-authorship network of co-authors of Kurt De Vlam
This figure shows the co-authorship network connecting the top 25 collaborators of Kurt De Vlam. A scholar is included among the top collaborators of Kurt De Vlam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt De Vlam. Kurt De Vlam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 139 | |
| 2 | 45 | |
| 3 | Classification models for disease: the effect of associations between markers on calculating the risk for disease by likelihood ratio products. | 1 |
| 4 | Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS) | 2 |
| 5 | 33 | |
| 6 | 54 | |
| 7 | Belgian patients with familial and sporadic ankylosing spondylitis differ in disease phenotype | 2 |
| 8 | Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years. | 107 |
| 9 | 92 | |
| 10 | 40 | |
| 11 | Is 99mTc human immunoglobulin G scintigraphy (HIG-scan) useful for the detection of spinal inflammation in ankylosing spondylitis? | 11 |
| 12 | A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis. | 75 |
| 13 | Radiological scoring methods in ankylosing spondylitis: reliability and sensitivity to change over one year. | 54 |
| 14 | 84 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.